Literature DB >> 7711873

Interleukin-6 and the thyroid.

L Bartalena1, S Brogioni, L Grasso, E Martino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7711873     DOI： 10.1530/eje.0.1320386

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  5 in total

Review 1.  Impact of COVID-19 on the thyroid gland: an update.

Authors:  Lorenzo Scappaticcio; Fabián Pitoia; Katherine Esposito; Arnoldo Piccardo; Pierpaolo Trimboli
Journal:  Rev Endocr Metab Disord       Date:  2020-11-25       Impact factor: 6.514

2.  Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.

Authors:  R M Ruggeri; D Villari; A Simone; R Scarfi; M Attard; F Orlandi; G Barresi; F Trimarchi; M Trovato; S Benvenga
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

3.  Subacute thyroiditis following recovery from COVID-19 infection: novel clinical findings from an Eastern Indian cohort.

Authors:  Sunetra Mondal; Riddhi DasGupta; Moushumi Lodh; Arunangshu Ganguly
Journal:  Postgrad Med J       Date:  2022-04-15       Impact factor: 4.973

Review 4.  Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives.

Authors:  Hidefumi Inaba; Toru Aizawa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

5.  Thyrotoxicosis in patients with COVID-19: the THYRCOV study.

Authors:  Andrea Lania; Maria Teresa Sandri; Miriam Cellini; Marco Mirani; Elisabetta Lavezzi; Gherardo Mazziotti
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.558
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.